[The] announced cuts to the list prices of the companys incretin products mark a repositioning for Novo, but remain too early as the company continues to lose ground to Lilly. Novos pricing announcement is the latest in a series of maneuvers after President Donald Trump threw the spotlight on the cost of GLP-1 drugs last year
Low-grade inflammation is a pathophysiologic factor in type 2 diabetes (T2D) and may have a significant impact on the development of diabetic complications, such as cardiovascular disease (CVD) [106,107,108]
Journal of Chromatography A
Semaglutide and Birth Control: The Absorption Problem Nobody Warns You About The phrase "Ozempic babies" circulated widely in 2023 and 2024, describing unintended pregnancies in women who were taking oral contraceptives while on semaglutide
Monitoring the cognitive effects of antiepileptic pharmacotherapy approaching the individual patient
For researchers starting at 2.5 mg weekly, a 10 mg vial is ideal